Regional Hot Spots, Part 2

Editor's Note: This is the second installment of a four-part series on regional hot spots for life sciences employment. Additional installments will appear in the July 9 and October 29 issues. San Francisco Bay Area boosters like to claim the title "Birthplace of Biotech" as their own. After all, the initial developments in recombinant DNA research took place through a collaboration by the labs of Herbert W. Boyer at University of California at San Francisco and Stanley Cohen at Stanford Univers

Written byHarvey Black
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Now, 25 years later, Genentech is but one of about 500 biotech firms that directly and indirectly account for some 120,000 jobs in the Bay Area. Most of the firms employ fewer than 49 people; Genentech, the largest, employs 3,000. The area's academic and research institutions provide work for another 10,000 people involved with life science projects.

The Bay Area Bioscience Center (www.bayareabioscience.org), which supplied many of the figures for this article, describes itself as "a public-private partnership and forum organized to strengthen the competitiveness of the region as the premier global location for bioscience research, education, and industry." According to Susan Day, president of the center, money from venture capitalists who helped the high-tech industry boom in Silicon Valley also helped biotech to boom in the Bay Area. The development of the NASDAQ, which somewhat parallels the same time frame, was also good fortune for biotech, she says. "[It] ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies